Result for the financial year ended 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sattva Sukun Lifecare Ltd reported strong FY25 results with revenue from operations rising to Rs. 526.30 lakhs from Rs. 355.33 lakhs (~48% growth). Profit After Tax doubled to Rs. 249.03 lakhs from Rs. 119.19 lakhs, while Profit Before Tax surged to Rs. 318.78 lakhs from Rs. 153.44 lakhs. Operating cash flow turned positive at Rs. 52.62 lakhs versus a negative Rs. 276.77 lakhs last year. Total assets stood at Rs. 2,658.30 lakhs with negligible debt. The company also announced a Rs. 48 crore Rights Issue at Rs. 1 per share in a 5:2 ratio, with record date set for 9th May 2025. Two independent directors resigned citing personal reasons, and a new non-executive director was appointed. The auditor issued an unmodified opinion on both standalone and consolidated results.
Strong earnings growth and margin expansion are positive for shareholders, though the upcoming Rs. 48 crore Rights Issue will significantly dilute existing equity (post-issue shares rise from 19.2 crore to 67.2 crore). Shareholders should evaluate their participation given the large dilution and ensure renunciation/subscription decisions are made before 11th June 2025.